UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001483
Receipt number R000001796
Scientific Title Phase I study of oral S-1 plus Gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer
Date of disclosure of the study information 2008/11/06
Last modified on 2014/05/06 09:34:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase I study of oral S-1 plus Gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer

Acronym

Phase I study of oral S-1 plus Gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer

Scientific Title

Phase I study of oral S-1 plus Gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer

Scientific Title:Acronym

Phase I study of oral S-1 plus Gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer

Region

Japan


Condition

Condition

Locally advanced pancreatic cancer

Classification by specialty

Hepato-biliary-pancreatic medicine Hepato-biliary-pancreatic surgery Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Our purposes are to evaluate the safety and feasibility and to determine recommended dose of oral S-1 plus Gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I


Assessment

Primary outcomes

safety
feasibility
maximum-tolerated dose
recommended dose

Key secondary outcomes

response rate at 4 weeks after accomplishment of whole treatment


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

Radiation: 1.8 Gy x 28 fr
S1: 60-80mg/sq x 28 days (synchronized with Radiation)
GEM: 200-300mg/sq x 6 fr(d1,8,15,22,29,36)
Level 0: S1(60mg/sq)+GEM(200mg/sq)
Level 1: S1(80mg/sq)+GEM(200mg/sq)
Level 2: S1(80mg/sq)+GEM(300mg/sq)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)A patient who has been diagnosed pancreatic cancer by diagnostic images and has been proven (or has a schedule for being proven) pancreatic adenocarcinoma histologically.
2)Locally advanced pancreatic cancer;
a)UICC stage II with portal or SMV invasion
b)UICC stage III
3)No prior operation, chemotherapy or radiotherapy
4)ECOG performance status of 0 or 1
5)Adequate hematologic, cardiac, pulmonary, hepatic and renal function
6)Total bilirubin level is less or equal 3.0mg/dL.
7)Written informed consent

Key exclusion criteria

1)Consciousness disorder
2)NYHA Class of II, III or IV
3)Interstitial pneumonia or pulmonary fibrosis
4)Liver dysfunction of Child-Pugh C
5)Requiring hemodialysis, or serum creatinine level is greater or equal 2.0mg/dL
6)Severe bleeding tendency
7)Poor nutrition (Lymphocyte count is less than 1200, Albumin level is less or equal 2.7g/dL or Pre-albumin level is less or equal 10mg/dL)
8)Acute inflammation
9)Direct invasion of stomach or bowel

Target sample size

12


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Goro Honda

Organization

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital

Division name

Hepato-Biliary-Pancreatic Surgery

Zip code


Address

3-18-22 Honkomagome, Bunkyo-ku, Tokyo

TEL

03-3823-2101

Email

ghon@cick.jp


Public contact

Name of contact person

1st name
Middle name
Last name Goro Honda

Organization

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital

Division name

Hepato-Biliary-Pancreatic Surgery

Zip code


Address

3-18-22 Honkomagome, Bunkyo-ku, Tokyo

TEL

03-3823-2101

Homepage URL


Email

ghon@cick.jp


Sponsor or person

Institute

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital

Institute

Department

Personal name



Funding Source

Organization

Japanese foundation for Multidisciplinary Treatment of Cancer

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)

Pancreas Research Foundation of Japan


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 11 Month 06 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 07 Month 07 Day

Date of IRB


Anticipated trial start date

2008 Year 07 Month 01 Day

Last follow-up date

2011 Year 12 Month 01 Day

Date of closure to data entry

2012 Year 12 Month 31 Day

Date trial data considered complete

2012 Year 12 Month 31 Day

Date analysis concluded

2013 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2008 Year 11 Month 06 Day

Last modified on

2014 Year 05 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001796


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name